146 related articles for article (PubMed ID: 33233443)
1. CYP26A1 Is a Novel Biomarker for Betel Quid-Related Oral and Pharyngeal Cancers.
Chen PH; Chung CM; Wang YY; Huang HW; Huang B; Lee KW; Yuan SS; Wu CW; Lin LS; Chan LP
Diagnostics (Basel); 2020 Nov; 10(11):. PubMed ID: 33233443
[TBL] [Abstract][Full Text] [Related]
2. Genetic and Proteinic Linkage of MAO and COMT with Oral Potentially Malignant Disorders and Cancers of the Oral Cavity and Pharynx.
Chen PH; Wang YY; Lan TH; Chan LP; Yuan SS
Cancers (Basel); 2021 Jun; 13(13):. PubMed ID: 34209963
[TBL] [Abstract][Full Text] [Related]
3. The influence of monoamine oxidase variants on the risk of betel quid-associated oral and pharyngeal cancer.
Chen PH; Huang B; Shieh TY; Wang YH; Chen YK; Wu JH; Huang JH; Chen CC; Lee KW
ScientificWorldJournal; 2014; 2014():183548. PubMed ID: 25389533
[TBL] [Abstract][Full Text] [Related]
4. Different impact from betel quid, alcohol and cigarette: risk factors for pharyngeal and laryngeal cancer.
Lee KW; Kuo WR; Tsai SM; Wu DC; Wang WM; Fang FM; Chiang FY; Ho KY; Wang LF; Tai CF; Kao EL; Chou SH; Lee CH; Chai CY; Ko YC
Int J Cancer; 2005 Dec; 117(5):831-6. PubMed ID: 15957167
[TBL] [Abstract][Full Text] [Related]
5. Association study between novel CYP26 polymorphisms and the risk of betel quid-related malignant oral disorders.
Wu SJ; Chen YJ; Shieh TY; Chen CM; Wang YY; Lee KT; Lin YM; Chien PH; Chen PH
ScientificWorldJournal; 2015; 2015():160185. PubMed ID: 25839051
[TBL] [Abstract][Full Text] [Related]
6. Cytochrome p450 metabolism of betel quid-derived compounds: implications for the development of prevention strategies for oral and pharyngeal cancers.
Lin CY; Pan TS; Ting CC; Liang SS; Huang SH; Liu HY; Ko EC; Wu CW; Tang JY; Chen PH
ScientificWorldJournal; 2013; 2013():618032. PubMed ID: 23983642
[TBL] [Abstract][Full Text] [Related]
7. The effects of arecoline on the release of cytokines using cultured peripheral blood mononuclear cells from patients with oral mucous diseases.
Hsu HJ; Chang KL; Yang YH; Shieh TY
Kaohsiung J Med Sci; 2001 Apr; 17(4):175-82. PubMed ID: 11482128
[TBL] [Abstract][Full Text] [Related]
8. Expression of a splice variant of CYP26B1 in betel quid-related oral cancer.
Chen PH; Lee KW; Hsu CC; Chen JY; Wang YH; Chen KK; Wang HM; Huang HW; Huang B
ScientificWorldJournal; 2014; 2014():810561. PubMed ID: 25114974
[TBL] [Abstract][Full Text] [Related]
9. The use of tobacco-free betel-quid in conjunction with alcohol/tobacco impacts early-onset age and carcinoma distribution for upper aerodigestive tract cancer.
Lee CH; Lee KW; Fang FM; Wu DC; Shieh TY; Huang HL; Chen CH; Chen PH; Chen MK; Kuo SJ; Chang CH; Tsai YS; Chiang SL; Tu HP; Chen BH; Ko YC
J Oral Pathol Med; 2011 Oct; 40(9):684-92. PubMed ID: 21385213
[TBL] [Abstract][Full Text] [Related]
10. The neoplastic impact of tobacco-free betel-quid on the histological type and the anatomical site of aerodigestive tract cancers.
Lee CH; Lee KW; Fang FM; Wu DC; Tsai SM; Chen PH; Shieh TY; Chen CH; Wu IC; Huang HL; Chen BH; Chang CH; Chen MK; Chou SH; Tsai YS; Chiang SL; Ko YC
Int J Cancer; 2012 Sep; 131(5):E733-43. PubMed ID: 22174014
[TBL] [Abstract][Full Text] [Related]
11. A study of betel quid carcinogenesis. 1. On the in vitro N-nitrosation of arecoline.
Wenke G; Hoffmann D
Carcinogenesis; 1983; 4(2):169-72. PubMed ID: 6825205
[TBL] [Abstract][Full Text] [Related]
12. Upregulated expression of MMP-9 in gingival epithelial cells induced by prolonged stimulation with arecoline.
Uehara O; Takimoto K; Morikawa T; Harada F; Takai R; Adhikari BR; Itatsu R; Nakamura T; Yoshida K; Matsuoka H; Nagayasu H; Saito I; Muthumala M; Chiba I; Abiko Y
Oncol Lett; 2017 Jul; 14(1):1186-1192. PubMed ID: 28693294
[TBL] [Abstract][Full Text] [Related]
13. Monoamine oxidase A variants are associated with heavy betel quid use.
Chen PH; Tu HP; Wang SJ; Ko AM; Lee CP; Chiang TA; Tsai YS; Lee CH; Shieh TY; Ko CH; Chiang SL; Ko YC
Addict Biol; 2012 Jul; 17(4):786-97. PubMed ID: 21521428
[TBL] [Abstract][Full Text] [Related]
14. Betel-quid dependence domains and syndrome associated with betel-quid ingredients among chewers: an Asian multi-country evidence.
Lee CH; Chiang SL; Ko AM; Hua CH; Tsai MH; Warnakulasuriya S; Ibrahim SO; Sunarjo ; Zain RB; Ling TY; Huang CL; Lane HY; Lin CC; Ko YC
Addiction; 2014 Jul; 109(7):1194-204. PubMed ID: 24650227
[TBL] [Abstract][Full Text] [Related]
15. Quantification of blood betel quid alkaloids and urinary 8-hydroxydeoxyguanosine in humans and their association with betel chewing habits.
Wu IC; Chen PH; Wang CJ; Wu DC; Tsai SM; Chao MR; Chen BH; Lee HH; Lee CH; Ko YC
J Anal Toxicol; 2010; 34(6):325-31. PubMed ID: 20663285
[TBL] [Abstract][Full Text] [Related]
16. Effects of arecoline on adipogenesis, lipolysis, and glucose uptake of adipocytes-A possible role of betel-quid chewing in metabolic syndrome.
Hsu HF; Tsou TC; Chao HR; Shy CG; Kuo YT; Tsai FY; Yeh SC; Ko YC
Toxicol Appl Pharmacol; 2010 Jun; 245(3):370-7. PubMed ID: 20406654
[TBL] [Abstract][Full Text] [Related]
17. Association of the
Qiu L; Yin RX; Khounphinith E; Li KG; Wang DS; Wu JZ
Int J Clin Exp Pathol; 2017; 10(12):11867-11879. PubMed ID: 31966551
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and associated factors of betel quid use in the Solomon Islands: a hyperendemic area for oral and pharyngeal cancer.
Tovosia S; Chen PH; Ko AM; Tu HP; Tsai PC; Ko YC
Am J Trop Med Hyg; 2007 Sep; 77(3):586-90. PubMed ID: 17827384
[TBL] [Abstract][Full Text] [Related]
19. Arecoline, a major alkaloid of areca nut, inhibits p53, represses DNA repair, and triggers DNA damage response in human epithelial cells.
Tsai YS; Lee KW; Huang JL; Liu YS; Juo SH; Kuo WR; Chang JG; Lin CS; Jong YJ
Toxicology; 2008 Jul; 249(2-3):230-7. PubMed ID: 18585839
[TBL] [Abstract][Full Text] [Related]
20. Pilot study of the pharmacokinetics of betel nut and betel quid biomarkers in saliva, urine, and hair of betel consumers.
Franke AA; Li X; Lai JF
Drug Test Anal; 2016 Oct; 8(10):1095-1099. PubMed ID: 26619803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
